Avendus Capital Advises Medikabazaar on Its USD 75 mn Fundraise Led by CREAEGIS & CDC Group
Medikabazaar, India’s leading B2B Healthtech platform announced that it has successfully raised USD 75 million Series C investment led by CREAEGIS, along with CDC Group, UK’s development finance institution and existing investors. The transaction also included USD 15 million of secondary sale by existing investors. Belgium based Ackermans & van Haaren (AvH), HealthQuad Advisors Private Limited, Japan-based Rebright Partners and Mitsui Sumitomo Insurance Venture Capital and Belgium-based KOIS Holdings were the existing investors who participated in the Series C round.
Avendus Capital acted as the exclusive financial advisor to Medikabazaar on the transaction.
About Medikabazaar
The current investment is the largest ever funding in the B2B Health-tech space. Medikabazaar, through its data driven AI and ML based platform, is addressing the market gap and supply chain inefficiencies, while also enhancing the demand prediction capabilities of the healthcare ecosystem. The funds are proposed to be utilized to strengthen Medikabazaar’s digital capabilities, deepen the supply ecosystem and technology driven distribution channels, and bolster capacity to provide a wider range of quality medical supplies across diverse geographical regions. This will also help Medikabazaar augment its international operations, especially across MENA and South East Asian markets.
REACH OUT
Get in touch with us
We believe in audacious goals and we are here to partner with you, every step of the way.
Explore how we can help your business scale
